Account
Inquiry
XCE Tirzepatide is a novel dual agonist targeting both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. This white lyophilized powder with 99% purity is specifically designed for research purposes only.
As a potential therapeutic agent for type 2 diabetes research, XCE Tirzepatide combines the effects of two incretin hormones in a single molecule. Its unique mechanism includes stimulating insulin secretion, suppressing glucagon release, delaying gastric emptying, and promoting satiety.
Research applications of XCE Tirzepatide include studies on: glucose metabolism regulation, weight management mechanisms, pancreatic β-cell function, and potential cardiovascular benefits. The compound has shown promising results in preclinical studies for metabolic disorder research.
Our XCE Tirzepatide is produced under strict GMP conditions, ensuring high quality and consistency for research purposes. Each batch undergoes rigorous quality control testing including HPLC purity analysis and mass spectrometry verification.
For research use only. Not for human consumption. Proper handling procedures should be followed when working with peptide compounds in laboratory settings.
